🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to message these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and claims of rapid British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Express Worries

However, physicians and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or prison.

Platform Reaction and Material Removal

Based on the social media company, the platform has taken down problematic material and banned associated hashtags and search suggestions. The organization stated it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found groups with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of slimming results, positive testimonials and detailed guides for preparing or administering at home.

Within minutes of joining one group, a seller shared WhatsApp details, where most transactions occur. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.

Item Details and Pricing

Inside these communities, messages show dark colored packages with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service said it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to potentially serious health risks”.